机译:抗病毒治疗期间的延迟病毒抑制与HB HB EAG阳性高病毒载慢性乙型肝炎的肝细胞癌率增加有关
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal MedicineYonsei University Wonju College of MedicineWonju‐si Korea;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
Department of Internal Medicine and Liver Research InstituteSeoul National University College of;
antiviral therapy; chronic hepatitis B; fibrosis; hepatocellular carcinoma; neucleos(t)ide;
机译:抗病毒治疗期间的延迟病毒抑制与HB HB EAG阳性高病毒载慢性乙型肝炎的肝细胞癌率增加有关
机译:抗病毒治疗期间的延迟病毒抑制与HB HB EAG阳性高病毒载慢性乙型肝炎的肝细胞癌率增加有关
机译:干扰素治疗降低了慢性丙型肝炎发展为肝细胞癌的速度,但在晚期阶段并未显着降低:一项针对1148例患者的回顾性研究。病毒性肝炎治疗研究组。
机译:非线性混合效应模拟慢性丙型肝炎未经治疗的患者的病毒载量
机译:黄曲霉毒素对中国的HPRT基因,乙型肝炎病毒感染以及随后发生的肝细胞癌的影响。
机译:丙型肝炎病毒感染的直接作用抗病毒治疗是否与肝移植前后肝细胞癌风险增加相关?
机译:是直接作用抗病毒治疗,用于肝细胞癌之前或之后肝移植前后的丙型肝炎病毒感染吗?